Home-based Progressive Resistance Exercise to Enhance Physical Performance of Older Adults With Possible Sarcopenia
1 other identifier
interventional
42
1 country
1
Brief Summary
The overall aim of the proposed project is to improve muscle strength in older adults with possible sarcopenia by promoting home-based progressive resistance exercise. The target population for health talks is community-dwelling older adults. A Three monthly home-visits and weekly phone calls will be made. A waitlist randomised controlled trial will be conducted to evaluate effectiveness, and qualitative feedback will be collected from participants. A pilot study will be conducted first.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedFirst Submitted
Initial submission to the registry
April 12, 2021
CompletedFirst Posted
Study publicly available on registry
April 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 7, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 7, 2024
CompletedMarch 28, 2025
March 1, 2025
3.9 years
April 12, 2021
March 27, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in lower-limb muscle strength at 12 weeks from baseline
Measured by Short Physical Performance Battery (SPPB), higher score indicates better performance
12 weeks after baseline
Secondary Outcomes (1)
Change in lower-limb muscle strength at 24 weeks from baseline
24 weeks after baseline
Other Outcomes (6)
Change in handgrip strength at 12 weeks from baseline
12 weeks after baseline
Change in handgrip strength at 24 weeks from baseline
24 weeks after baseline
Status of possible sarcopenia at 12 weeks from baseline
12 weeks after baseline
- +3 more other outcomes
Study Arms (2)
Intervention
EXPERIMENTALThe intervention is a 12-week home-based resistance training programme with phased progression. The intervention will have three phases: (i) an initial phase focused on training the target muscle(s)/movements with minimal or no external weight; (ii) an intermediate phase targeting muscle strength with increased practice resistance; and (iii) an advanced phase targeting the further enhancement of muscle strength by challenging multiple muscle groups. Each phase will involve exercises targeting the trunk, back, hip, upper-limb and lower-limb muscles.
Waitlist control
OTHERThe waitlist control participants will start the intervention 12 weeks after the baseline assessment.
Interventions
The intervention is to be taught by fitness trainer at the participants' home at the start of each phase. The exercise progression model for older adults recommended by the American College of Sports Medicine, which emphasise gradual increments in training load and systematically alter one or more programme components, will be adopted.
Eligibility Criteria
You may qualify if:
- Aged 65-89;
- Possible sarcopenia (defined by AWGS 2019);
- No cognitive impairment (Abbreviated Mental Test score ≥8); and
- No communication problems.
You may not qualify if:
- having engaged in a structured exercise programme in the past 6 months or planning to do so within the intervention period;
- mobility-limiting injury of the hands or lower limbs, surgery or hospitalisation within the intervention period;
- contraindications such as musculoskeletal/cardiorespiratory disorders, or any advanced diseases that inhibit them from exercising.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Community
Hong Kong, Hong Kong
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 12, 2021
First Posted
April 20, 2021
Study Start
January 1, 2021
Primary Completion
November 7, 2024
Study Completion
November 7, 2024
Last Updated
March 28, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share
To protect confidentiality of participants.